Recovery of platelet reactivity following cessation of either aspirin or ticagrelor in patients treated with dual antiplatelet therapy following percutaneous coronary intervention: a GLOBAL LEADERS substudy.
Aspirin
percutaneous coronary intervention
platelet aggregation
ticagrelor
Journal
Platelets
ISSN: 1369-1635
Titre abrégé: Platelets
Pays: England
ID NLM: 9208117
Informations de publication
Date de publication:
02 Jan 2022
02 Jan 2022
Historique:
pubmed:
29
12
2020
medline:
5
3
2022
entrez:
28
12
2020
Statut:
ppublish
Résumé
Cessation of one component of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) has been associated with increased risk of ischemic events but it is uncertain whether discontinuation of aspirin is preferable to discontinuation of the oral P2Y
Identifiants
pubmed: 33356730
doi: 10.1080/09537104.2020.1863937
doi:
Substances chimiques
Platelet Aggregation Inhibitors
0
Ticagrelor
GLH0314RVC
Aspirin
R16CO5Y76E
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
141-146Subventions
Organisme : British Heart Foundation
ID : FS/18/49/33752
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/14/97/31263
Pays : United Kingdom